40 related articles for article (PubMed ID: 19080259)
1. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
2. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100.
Gökşen Tosun N
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3249-3259. PubMed ID: 37917369
[TBL] [Abstract][Full Text] [Related]
3. Apatinib increases anticancer potential of doxorubicin in breast cancer cells.
Aghaei E; Soltanzadeh H; Kohan L; Heiat M
Mol Biol Rep; 2023 Dec; 50(12):10137-10145. PubMed ID: 37921980
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
Urbaniak A; Jablonska K; Suchanski J; Partynska A; Szymczak-Kulus K; Matkowski R; Maciejczyk A; Ugorski M; Dziegiel P
Sci Rep; 2023 Apr; 13(1):6574. PubMed ID: 37085653
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated Hsp27 promotes adriamycin resistance in breast cancer cells through regulating dual phosphorylation of c-Myc.
Bi X; Zhang M; Zhou J; Yan X; Cheng L; Luo L; Huang C; Yin Z
Cell Signal; 2023 Dec; 112():110913. PubMed ID: 37797796
[TBL] [Abstract][Full Text] [Related]
6. Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways.
Abooshahab R; Al-Salami H; Dass CR
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474001
[TBL] [Abstract][Full Text] [Related]
7. Synergistic induction of apoptosis in liver cancer cells: exploring the combined potential of doxorubicin and XL-888.
Kaplan Ö
Med Oncol; 2023 Oct; 40(11):318. PubMed ID: 37794195
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin inhibits miR-140 expression and upregulates PD-L1 expression in HCT116 cells, opposite to its effects on MDA-MB-231 cells.
Naba NM; Tolay N; Erman B; Sayi Yazgan A
Turk J Biol; 2020; 44(1):15-23. PubMed ID: 32123492
[TBL] [Abstract][Full Text] [Related]
9. Auranofin sensitizes breast cancer cells to paclitaxel chemotherapy by disturbing the cellular redox system.
Natarajan D; Prasad NR; Sudharsan M; Bharathiraja P; Lakra DS
Cell Biochem Funct; 2023 Dec; 41(8):1305-1318. PubMed ID: 37792847
[TBL] [Abstract][Full Text] [Related]
10. L-lysine Increases the Anticancer Effect of Doxorubicin in Breast Cancer by Inducing ROS-Dependent Autophagy.
Jahani M; Yarani R; Rezazadeh D; Tahmasebi H; Hoseinkhani Z; Kiani S; Mansouri K
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38584530
[TBL] [Abstract][Full Text] [Related]
11. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line.
Lafi Z; Alshaer W; Gharaibeh L; Alqudah DA; AlQuaissi B; Bashaireh B; Ibrahim AA
PLoS One; 2023; 18(9):e0291981. PubMed ID: 37768997
[TBL] [Abstract][Full Text] [Related]
12. Sulfated polysaccharide-protein complex sensitizes doxorubicin-induced apoptosis of breast cancer cells
Wang J; Wu HJ; Zhou CZ; Wang H
Exp Ther Med; 2016 Oct; 12(4):2169-2176. PubMed ID: 27698706
[TBL] [Abstract][Full Text] [Related]
13.
Mody H; Vaidya TR; Lezeau J; Taha K; Ait-Oudhia S
Front Pharmacol; 2023; 14():1239141. PubMed ID: 37927589
[TBL] [Abstract][Full Text] [Related]
14. Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin.
Pusuluri A; Krishnan V; Wu D; Shields CW; Wang LW; Mitragotri S
Bioeng Transl Med; 2019 May; 4(2):e10129. PubMed ID: 31249879
[TBL] [Abstract][Full Text] [Related]
15. Functionalized magnetic nanowires for chemical and magneto-mechanical induction of cancer cell death.
Martínez-Banderas AI; Aires A; Teran FJ; Perez JE; Cadenas JF; Alsharif N; Ravasi T; Cortajarena AL; Kosel J
Sci Rep; 2016 Oct; 6():35786. PubMed ID: 27775082
[TBL] [Abstract][Full Text] [Related]
16. The Role of Hsp27 in Chemotherapy Resistance.
Lampros M; Vlachos N; Voulgaris S; Alexiou GA
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453647
[TBL] [Abstract][Full Text] [Related]
17. Could Increased Expression of Hsp27, an "Anti-Inflammatory" Chaperone, Contribute to the Monocyte-Derived Dendritic Cell Bias towards Tolerance Induction in Breast Cancer Patients?
de Azevedo-Santos APS; Rocha MCB; Guimarães SJA; Vale AAM; Laginha FM; Nascimento FRF; Nagai MA; Bergami-Santos PC; Barbuto JAM
Mediators Inflamm; 2019; 2019():8346930. PubMed ID: 31827382
[TBL] [Abstract][Full Text] [Related]
18. Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia.
Lu X; Wu Z; Zhao XY; Li CF; Kan SF
Oncol Lett; 2019 Feb; 17(2):2351-2355. PubMed ID: 30675301
[TBL] [Abstract][Full Text] [Related]
19. Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.
Kim JH; Jung YJ; Choi B; Lee NL; Lee HJ; Kwak SY; Kwon Y; Na Y; Lee YS
Oncotarget; 2016 Aug; 7(33):53178-53190. PubMed ID: 27449291
[TBL] [Abstract][Full Text] [Related]
20. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
